S&P 500, NASDAQ HOLD NEAR RECORDS; NVIDIA DIPS

Oil gains as ECB lowers rates, Saudi Arabia signals flexibility on output cut phaseout

BIIB Jan 2025 205.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

21.15

0.00

(0.00%)

As of 10:43AM EDT. Market open.

Loading interactive chart...

Zacks
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
GSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.
Zacks
Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.